Rankings
▼
Calendar
EBS FY 2007 Earnings — Emergent BioSolutions Inc. Revenue & Financial Results | Market Cap Arena
EBS
Emergent BioSolutions Inc.
$427M
FY 2007 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$183M
+19.8% YoY
Gross Profit
$143M
78.0% margin
Operating Income
$33M
18.1% margin
Net Income
$23M
12.5% margin
EPS (Diluted)
$0.77
Cash Flow
Operating Cash Flow
$55M
Free Cash Flow
$11M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$274M
Total Liabilities
$102M
Stockholders' Equity
$171M
Cash & Equivalents
$106M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$183M
$153M
+19.8%
Gross Profit
$143M
$129M
+10.9%
Operating Income
$33M
$38M
-13.0%
Net Income
$23M
$23M
+0.6%
← FY 2006
All Quarters
FY 2008 →